NCT04736953View on ClinicalTrials.gov

Sirolimus Treatment Of Patients With SLE

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2029

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG

Sirolimus

Sirolimus

OTHER

Placebo

Placebo

All Listed Sponsors

lead

State University of New York - Upstate Medical University

OTHER